Belinda Shipman told Newsweek that the monthlong treatment felt like her "face, body and mind were literally being torn apart ...
Advances in cancer treatment mean more people are living longer after a cancer diagnosis. But some survivors develop ...
A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) issued a clarification of previously reported Phase 2 trial results for ...
SkinJect™ , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...
Popular New York City meteorologist Sam Champion is returning to "Good Morning America" after needing an unexpected heart procedure. The longtime ABC weather anchor shared the news in an Instagram ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Spots, bumps or patches that suddenly appear on your skin can be alarming, especially if they grow quickly, become red or irritated, or do not seem to heal. It can be difficult to tell whether it is ...
The sNDA filing acceptance initiates substantive FDA review for Ameluz PDT in sBCC, with a target action date of Sept. 28, 2026 and no identified filing deficiencies. Approval would establish the ...
There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results